| 注册
首页|期刊导航|国际医药卫生导报|和胃宝胶囊治疗幽门螺杆菌和消化性溃疡的临床研究

和胃宝胶囊治疗幽门螺杆菌和消化性溃疡的临床研究

马国亮 朱成全

国际医药卫生导报2017,Vol.23Issue(12):1937-1940,4.
国际医药卫生导报2017,Vol.23Issue(12):1937-1940,4.DOI:10.3760/cma.j.issn.1007-1245.2017.12.040

和胃宝胶囊治疗幽门螺杆菌和消化性溃疡的临床研究

Clinical study of Heweibao capsule in the treatment of helicobacter pylori and peptic ulcer

马国亮 1朱成全1

作者信息

  • 1. 510318 广州,解放军第421医院
  • 折叠

摘要

Abstract

Objective To observe the curative effect of Hevveibao capsule on helicobacter pylori eradication and peptic ulcer.Methods Patients with peptic ulcer were randomly divided into Heweibao treatment group and western medicine control group.The control group was treated with conventional western medicine,and the treatment group was treated with oral Heweibao capsule on the basis of the control group,3 grains/time,3 times/d.The two groups were treated for 2 weeks.Compared gastroduodenal mucosal injury,helicobacter pylori eradication rate and clinical efficacy of the two groups.Results The improvement rate of symptoms of the treatment group was 96.2%,the rate of adverse reactions was 2.94%,the score of gastric mucosal injury was (0.76±0.16),the score of duodenal mucosal injury was (0.80±0.18),those of the control group were 83.6%,27.72%,(1.52±0.28),(1.47±0.31),with statistically significant differences between the two groups (P<0.05).The total treatment effective rate of gastric ulcer,duodenal ulcer,compound ulcer of the treatment group were 93.9%,93.4%,87.5%,the helicobacter pylori eradication rate was 94.1%,those of the control group were 90.3%,96.9%,66.7%,93.1%,without statistically significant differences between the two groups (P>0.05).Conclusion Heweibao capsule is effective in the treatment ofhelicobacter pylori and peptic ulcer,worthy to be popularized in the clinical treatment.

关键词

和胃宝胶囊/消化性溃疡/幽门螺杆菌

Key words

Heweibao capsule/Peptic ulcer/Helicobacter pylori

引用本文复制引用

马国亮,朱成全..和胃宝胶囊治疗幽门螺杆菌和消化性溃疡的临床研究[J].国际医药卫生导报,2017,23(12):1937-1940,4.

国际医药卫生导报

1007-1245

访问量0
|
下载量0
段落导航相关论文